Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients

Annals of the Rheumatic Diseases

Volumn 72, Issue 12, 2013, Pages 2053-2055

  Hissink Muller, P C E ^a   Anink, J ^b   Shi, J ^a   Levarht, E W N ^a   Reinards, T H C M ^a   Otten, M H ^b   Van Tol, M J D ^a   Jol Van Der Zijde, C M ^a   Brinkman, D M C ^a   Allaart, C F ^a   Hoppenreijs, E P ^c   Koopman Keemink, Y ^d   Kamphuis, S S M ^b   Dolman, K ^e   Van Den Berg, J M ^f   Van Rossum, M A J ^f   Van Suijlekom Smit, L W A ^b   Schilham, M W ^a   Huizinga, T W J ^a   Toes, R E M ^a   Ten Cate, R ^a   Trouw, L A ^a   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d JULIANA CHILDREN S HOSPITAL   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMYLATED PROTEIN ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; PROTEIN ANTIBODY; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; COHORT ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; PRIORITY JOURNAL; PROGNOSIS;

ANT-CCP; CHEMOKINES; JUVENILE IDIOPATHIC ARTHRITIS;

ADOLESCENT; ARTHRITIS, JUVENILE; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARBAMATES; CHILD; FEMALE; HUMANS; MALE; PROTEINS;

EID: 84887496355     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203650     Document Type: Letter

References (10)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094-108.
2. Syed RH, Gilliam BE, Moore TL. Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology. Curr Rheumatol Rep 2008;10:156-63.
3. Shi J, Knevel R, Suwannalai P, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA 2011;108:17372-77.
4. Shi J, Van De Stadt LA, Levarht EW, et al. Brief report: anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum 2013;65:911-15.
5. Trouw LA, Huizinga TW, Toes RE. Autoimmunity in rheumatoid arthritis: different antigens-common principles. Ann Rheum Dis 2013;72(Suppl 2):32-36.
6. Albers HM, Brinkman DM, Kamphuis SS, et al. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2010;62:204-12.
7. Otten MH, Prince FH, Armbrust W, et al. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA 2011;306:2340-7.
8. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
9. Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
10. Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011;63:929-36.